These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 39113897)
1. Identification and Validation of Prognostic Markers for Endometriosis-Associated Ovarian Cancer. Yang H; Deng Y; Dong Y; Ma Y; Yang L Int J Med Sci; 2024; 21(10):1903-1914. PubMed ID: 39113897 [No Abstract] [Full Text] [Related]
2. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Suryawanshi S; Vlad AM; Lin HM; Mantia-Smaldone G; Laskey R; Lee M; Lin Y; Donnellan N; Klein-Patel M; Lee T; Mansuria S; Elishaev E; Budiu R; Edwards RP; Huang X Clin Cancer Res; 2013 Mar; 19(5):1213-24. PubMed ID: 23362326 [TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis. Ponandai-Srinivasan S; Andersson KL; Nister M; Saare M; Hassan HA; Varghese SJ; Peters M; Salumets A; Gemzell-Danielsson K; Lalitkumar PGL Hum Reprod; 2018 Oct; 33(10):1924-1938. PubMed ID: 30020448 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of shared genes and key pathways in endometriosis and endometriosis-associated ovarian cancer by weighted gene co-expression network analysis and machine learning algorithms. Du Y; Hu Y; Zhang F; Guan Y; Sheng Y J Obstet Gynaecol Res; 2023 Aug; 49(8):2135-2150. PubMed ID: 37340502 [TBL] [Abstract][Full Text] [Related]
5. Identification of differentially methylated genes in the malignant transformation of ovarian endometriosis. Ren F; Wang DB; Li T; Chen YH; Li Y J Ovarian Res; 2014 Jul; 7():73. PubMed ID: 25298284 [TBL] [Abstract][Full Text] [Related]
6. Screening differentially expressed genes between endometriosis and ovarian cancer to find new biomarkers for endometriosis. Lu Z; Gao Y Ann Med; 2021 Dec; 53(1):1377-1389. PubMed ID: 34409913 [TBL] [Abstract][Full Text] [Related]
7. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Erzen M; Rakar S; Klancnik B; Syrjänen K Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420 [TBL] [Abstract][Full Text] [Related]
8. MiR-191 modulates malignant transformation of endometriosis through regulating TIMP3. Dong M; Yang P; Hua F Med Sci Monit; 2015 Mar; 21():915-20. PubMed ID: 25819812 [TBL] [Abstract][Full Text] [Related]
10. The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer. Andersen CL; Boisen MM; Sikora MJ; Ma T; Tseng G; Suryawanshi S; Vlad A; Elishaev E; Edwards RP; Oesterreich S Horm Cancer; 2018 Dec; 9(6):399-407. PubMed ID: 30302736 [TBL] [Abstract][Full Text] [Related]
11. Identification of metastasis and prognosis-associated genes for serous ovarian cancer. Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146 [TBL] [Abstract][Full Text] [Related]
12. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs. Zhao Q; Fan C BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053 [TBL] [Abstract][Full Text] [Related]
13. The High Expression of RRM2 Can Predict the Malignant Transformation of Endometriosis. Yang B; Wang T; Li N; Zhang W; Hu Y Adv Ther; 2021 Oct; 38(10):5178-5190. PubMed ID: 34424503 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Clinical Characteristics and Prognostic Factors Related to EMs Correlation in Ovarian Cancer Patients. Zheng Q; Chen S; Chen L; Wang J Altern Ther Health Med; 2024 Aug; 30(8):104-107. PubMed ID: 38290463 [TBL] [Abstract][Full Text] [Related]
15. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer. Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370 [TBL] [Abstract][Full Text] [Related]
16. The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer. Banz C; Ungethuem U; Kuban RJ; Diedrich K; Lengyel E; Hornung D Fertil Steril; 2010 Sep; 94(4):1212-1217. PubMed ID: 19643405 [TBL] [Abstract][Full Text] [Related]
17. Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis. Chang CM; Yang YP; Chuang JH; Chuang CM; Lin TW; Wang PH; Yu MH; Chang CC Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113136 [TBL] [Abstract][Full Text] [Related]
18. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer. Suryawanshi S; Huang X; Elishaev E; Budiu RA; Zhang L; Kim S; Donnellan N; Mantia-Smaldone G; Ma T; Tseng G; Lee T; Mansuria S; Edwards RP; Vlad AM Clin Cancer Res; 2014 Dec; 20(23):6163-74. PubMed ID: 25294912 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and serum CA19-9 combined with HE4 are valuable in diagnosing endometriosis-associated ovarian cancer. Xu T; Zhang L; Jiang Y; Wan Y; Zhou S; Sun G; Cheng W; Yuan L Int J Gynaecol Obstet; 2023 Aug; 162(2):472-478. PubMed ID: 36708088 [TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis]. Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473 [No Abstract] [Full Text] [Related] [Next] [New Search]